These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 1540240)
1. Activation of human leukemia protein kinase C by tumor promoters and its inhibition by N-trifluoroacetyladriamycin-14-valerate (AD 32). Chuang LF; Kung HF; Israel M; Chuang RY Biochem Pharmacol; 1992 Feb; 43(4):865-72. PubMed ID: 1540240 [TBL] [Abstract][Full Text] [Related]
2. Effects of tannic acid on 12-O-tetradecanoylphorbol-13-acetate-induced protein kinase C activation in NIH 3T3 cells. Kuo ML; Wu WS; Lee KC; Lin JK Biochem Pharmacol; 1993 Oct; 46(8):1327-32. PubMed ID: 8240380 [TBL] [Abstract][Full Text] [Related]
3. In vitro model for intrinsic drug resistance: effects of protein kinase C activators on the chemosensitivity of cultured human colon cancer cells. Dong ZY; Ward NE; Fan D; Gupta KP; O'Brian CA Mol Pharmacol; 1991 Apr; 39(4):563-9. PubMed ID: 2017156 [TBL] [Abstract][Full Text] [Related]
4. TPA-enhanced motility and invasion in a highly metastatic variant (L-10) of human rectal adenocarcinoma cell line RCM-1: selective role of PKC-alpha and its inhibition by a combination of PDBu-induced PKC downregulation and antisense oligonucleotides treatment. Shimao Y; Nabeshima K; Inoue T; Koono M Clin Exp Metastasis; 1999 Jun; 17(4):351-60. PubMed ID: 10545022 [TBL] [Abstract][Full Text] [Related]
5. Protein kinase C-alpha produces reciprocal effects on the phorbol ester stimulated tyrosine phosphorylation of a 50 kDa kinase in Jurkat cells. Borowski P; Roloff S; Medem S; Kühl R; Laufs R Biol Chem; 1999 Apr; 380(4):403-12. PubMed ID: 10355626 [TBL] [Abstract][Full Text] [Related]
6. Role of protein kinase C in bradykinin-induced prostaglandin formation in osteoblasts. Ljunggren O; Fredholm BB; Nordstedt C; Ljunghall S; Lerner UH Eur J Pharmacol; 1993 Jan; 244(2):111-7. PubMed ID: 8432308 [TBL] [Abstract][Full Text] [Related]
7. Cellular uptake and localization of fluorescent derivatives of phorbol ester tumor promoters. Liskamp RM; Brothman AR; Arcoleo JP; Miller OJ; Weinstein IB Biochem Biophys Res Commun; 1985 Sep; 131(2):920-7. PubMed ID: 3863618 [TBL] [Abstract][Full Text] [Related]
8. Contrasting effects of phorbol ester and agonist-mediated activation of protein kinase C on phosphoinositide and Ca2+ signalling in a human neuroblastoma. Willars GB; Challiss RA; Stuart JA; Nahorski SR Biochem J; 1996 Jun; 316 ( Pt 3)(Pt 3):905-13. PubMed ID: 8670170 [TBL] [Abstract][Full Text] [Related]
9. Involvement of protein kinase C in translocation of desmoplakins from cytosol to plasma membrane during desmosome formation in human squamous cell carcinoma cells grown in low to normal calcium concentration. Sheu HM; Kitajima Y; Yaoita H Exp Cell Res; 1989 Nov; 185(1):176-90. PubMed ID: 2509226 [TBL] [Abstract][Full Text] [Related]
10. Effects of thioether phospholipid BM 41.440 on protein kinase C and phorbol ester-induced differentiation of human leukemia HL60 and KG-1 cells. Shoji M; Raynor RL; Berdel WE; Vogler WR; Kuo JF Cancer Res; 1988 Dec; 48(23):6669-73. PubMed ID: 3180076 [TBL] [Abstract][Full Text] [Related]
11. Protein kinase C levels and protein phosphorylation associated with inhibition of proliferation in a murine macrophage tumor. Goode NT; Hart IR J Cell Physiol; 1990 Mar; 142(3):480-7. PubMed ID: 2312612 [TBL] [Abstract][Full Text] [Related]
12. Mechanistic studies on the DDT-induced inhibition of intercellular communication. Wärngård L; Hemming H; Flodström S; Duddy SK; Kass GE Carcinogenesis; 1989 Mar; 10(3):471-6. PubMed ID: 2564319 [TBL] [Abstract][Full Text] [Related]
13. Interaction of the novel anthracycline antitumor agent N-benzyladriamycin-14-valerate with the C1-regulatory domain of protein kinase C: structural requirements, isoform specificity, and correlation with drug cytotoxicity. Roaten JB; Kazanietz MG; Caloca MJ; Bertics PJ; Lothstein L; Parrill AL; Israel M; Sweatman TW Mol Cancer Ther; 2002 May; 1(7):483-92. PubMed ID: 12479266 [TBL] [Abstract][Full Text] [Related]
14. Characterization of phorbol ester binding to protein kinase C isotypes. Dimitrijević SM; Ryves WJ; Parker PJ; Evans FJ Mol Pharmacol; 1995 Aug; 48(2):259-67. PubMed ID: 7651359 [TBL] [Abstract][Full Text] [Related]
15. Selection and preliminary characterization of variant lines of a murine macrophage tumor resistant to the antiproliferative effects of phorbol esters. Goode NT; Moore JP; Hart IR Cancer Res; 1990 Mar; 50(5):1510-5. PubMed ID: 2105841 [TBL] [Abstract][Full Text] [Related]
16. A phorbol diester resistant monocytic leukemia cell line is PKC deficient. Ansari NA; Wu MC Int J Cell Cloning; 1992 Jan; 10(1):47-53. PubMed ID: 1313072 [TBL] [Abstract][Full Text] [Related]
17. CGP 41251 and tamoxifen selectively inhibit mitogen-activated protein kinase activation and c-Fos phosphoprotein induction by substance P in human astrocytoma cells. Luo W; Sharif TR; Houghton PJ; Sharif M Cell Growth Differ; 1997 Nov; 8(11):1225-40. PubMed ID: 9372245 [TBL] [Abstract][Full Text] [Related]
18. Protein kinase C and the opposite regulation of sodium channel alpha- and beta1-subunit mRNA levels in adrenal chromaffin cells. Yanagita T; Kobayashi H; Yamamoto R; Takami Y; Yokoo H; Yuhi T; Nakayama T; Wada A J Neurochem; 1999 Oct; 73(4):1749-57. PubMed ID: 10501224 [TBL] [Abstract][Full Text] [Related]
19. Activation of protein kinase C subtypes alpha, gamma, delta, epsilon, zeta, and eta by tumor-promoting and nontumor-promoting agents. Geiges D; Meyer T; Marte B; Vanek M; Weissgerber G; Stabel S; Pfeilschifter J; Fabbro D; Huwiler A Biochem Pharmacol; 1997 Mar; 53(6):865-75. PubMed ID: 9113106 [TBL] [Abstract][Full Text] [Related]
20. A selective effect of protein kinase C activators on noradrenaline release compared with subsequent contraction in canine isolated saphenous veins. Takata Y; Ozawa J; Kato H Br J Pharmacol; 1991 Apr; 102(4):955-61. PubMed ID: 1855124 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]